Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Rational Analyst -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (1288)	7/23/1998 2:12:00 AM
From: HeyRainier	Read Replies (1) \| Respond to of 1720

[ ISIP ] Scott, There is extreme price congestion up to and at the $19.00 level. Any sell between $18.00 and $19.00 is a good selling point IMO based on the stock's supply/demand relationship. In the event that a higher high is hit, I would expect it to stop at a maximum of 20.5, at which I would probably consider a short position because of the likelihood of a pullback from such levels. But that's Super Dave's territory. That's his new name now, by the way. <gg> Regards, Rainier

To: Scott H. Davis who wrote (1288)	7/23/1998 2:22:00 AM
From: HeyRainier	Read Replies (1) \| Respond to of 1720

Hmm...approval for a drug treatment is uncharted territory for me, however. Sometimes the supply/demand rules are so bent out of shape after such an approval (like ENMD), that it becomes hard to predict where it will go. I will defer to others who have more experience with the biotech field. My analysis tends to deal more with rational and even sometimes exuberant price moves. We'll see early tomorrow if ISIP falls within such boundaries. (Of course, I won't be around at all to see such a development. I got lucky tonight I was able to post. I'll probably be able to do this again in another following two weeks.) Good luck. Rainier